查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942524

2026年全球心臟基因检测市场报告

Cardiogenomics Testing Panels Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，心臟基因组检测市场发展迅速，预计将从2025年的15.5亿美元成长到2026年的17.5亿美元，复合年增长率达12.6%。过去几年的成长可归因于多种因素，例如心血管疾病盛行率的上升、基因检测的普及程度有限、人们对遗传性心臟疾病的认识不断提高、传统心血管诊断技术的广泛应用以及早期定序技术的高成本。

预计未来几年，心臟基因组检测市场将快速成长，到2030年市场规模将达到27.8亿美元，复合年增长率（CAGR）为12.3%。预测期内的成长要素包括：次世代定序（NGS）技术的进步、人工智慧和生物资讯学在诊断领域的融合、政府对精准医疗的支持措施、多基因和全EXOME显子组检测的日益普及，以及对个人化心血管照护需求的不断增长。预测期内的主要趋势包括：个人化基因风险评估、人工智慧驱动的诊断工具、远端心电图诊断和监测、多基因检测的整合以及先进的生物资讯平台。

遗传性心血管疾病盛行率的上升预计将推动心臟基因组检测市场的成长。遗传性心血管疾病（ICD）是指由父母遗传给子女的心臟和血管疾病。基因检测和诊断技术的进步使得以往难以识别的疾病能够被更准确地检测出来，从而促进了确诊病例的增加。心臟基因组检测可以分析导致遗传性心臟病的基因突变，从而支持早期诊断、风险评估和製定个人化治疗方案。例如，根据英国社区健康中心联合策略需求评估机构（Joint Strategic Needs Assessment）于2025年2月发布的报告，布莱克浦2023年记录的心血管疾病死亡人数为185人，高于2022年的178人。这一成长趋势正在推动心臟基因组检测市场的扩张。

预计未来几年，不断增长的医疗费用支出将推动心臟基因组检测市场的发展。医疗保健支出是指政府、私人机构和个人用于提供、维护和改善医疗保健服务的总资源，包括资金。医疗保健支出成长的主要原因是需要长期治疗、持续监测和专业医疗介入的慢性病数量增加。这些支出为心臟基因组检测提供了支持，用于进行先进的基因分析，从而能够早期发现和预防遗传性心血管疾病，改善患者预后并降低长期成本。例如，根据英国国家统计局2024年5月发布的报告，预计2023年医疗保健总支出名目值将增加5.6%，较2022年下降0.9%。因此，不断增长的医疗保健支出正在推动心血管基因组检测市场的成长。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球心臟基因检测市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 个人化基因风险分析
    • 人工智慧驱动的诊断工具
    • 远距心臟病学和远端监测
    • 多基因面板整合
    • 高级生物资讯平台

第五章 终端用户产业市场分析

  • 医院和诊所
  • 诊断检查室
  • 学术研究机构
  • 心臟病中心
  • 专业基因检测中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球心臟基因检测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球心臟基因检测市场规模、比较及成长率分析
  • 全球心臟基因检测市场表现：规模与成长，2020-2025年
  • 全球心臟基因检测市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 依产品类型
  • 单基因panel、多基因panel和全EXOME显子定序panel
  • 透过技术
  • 次世代定序、基于PCR的检测、微阵列和其他技术
  • 透过使用
  • 遗传性心血管疾病、心律不整、心肌病、先天性心臟疾病及其他应用
  • 最终用户
  • 医院/诊所、诊断检查室、学术研究机构和其他最终用户
  • 按类型细分：单基因检测
  • 离子通道基因检测、结构性心臟疾病基因检测、心律不整基因检测
  • 按类型细分：多基因检测
  • 心肌病筛检、心律不整筛检、先天性心臟疾病筛检
  • 按类型细分：全EXOME定序panel
  • 标靶心血管EXOME定序、综合EXOME定序与研究性EXOME子定序

第十章 区域与国家分析

  • 全球心臟基因检测市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球心臟基因检测市场：依国家、市场表现及预测（2020-2025年、2025-2030年预测、2035年预测）

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 心臟基因检测市场：竞争格局及市场占有率（2024年）
  • 心臟基因检测市场：公司估值矩阵
  • 心臟基因检测市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific, Inc.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Eurofins Scientific SE

第37章：其他领先和创新企业

  • Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix SL, Asper Biotech Ltd.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年心臟基因检测市场：提供新机会的国家
  • 2030年心臟基因检测市场：新兴细分市场机会
  • 2030年心臟基因检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MCTPE01_G26Q1

Cardiogenomics testing panels are genetic tests that examine multiple genes to determine inherited risks for cardiovascular diseases, including cardiomyopathies, arrhythmias, and familial hypercholesterolemia. They support early diagnosis, personalized treatment, and assessment of family risk.

The primary product types of cardiogenomics testing panels are single-gene panels, multi-gene panels, and whole exome sequencing panels. Single-gene panels test a specific gene to detect mutations or variants linked to a particular inherited condition or disease. The technologies employed include next-generation sequencing, PCR-based testing, microarrays, and others. These panels are applied in areas such as inherited cardiovascular diseases, arrhythmias, cardiomyopathies, congenital heart diseases, and others, and are used by hospitals and clinics, diagnostic laboratories, academic and research institutions, and other end users.

Tariffs are impacting the cardiogenomics testing panels market by increasing the cost of importing sequencing instruments, reagents, and consumables, particularly impacting regions such as North America, Europe, and Asia-Pacific where most advanced equipment is sourced from specialized suppliers. The resulting cost increase has slowed adoption in smaller diagnostic labs, while larger hospitals and academic institutes have mitigated the effect through local sourcing or partnerships. Positive impacts include incentivizing domestic manufacturing of certain testing kits and consumables, potentially reducing future dependency on imports and lowering costs over time.

The cardiogenomics testing panels market research report is one of a series of new reports from The Business Research Company that provides cardiogenomics testing panels market statistics, including cardiogenomics testing panels industry global market size, regional shares, competitors with a cardiogenomics testing panels market share, detailed cardiogenomics testing panels market segments, market trends and opportunities, and any further data you may need to thrive in the cardiogenomics testing panels industry. This cardiogenomics testing panels market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiogenomics testing panels market size has grown rapidly in recent years. It will grow from $1.55 billion in 2025 to $1.75 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, limited access to genetic testing, increasing awareness of inherited cardiac disorders, adoption of conventional cardiovascular diagnostic techniques, high cost of early sequencing technologies.

The cardiogenomics testing panels market size is expected to see rapid growth in the next few years. It will grow to $2.78 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to advancements in next-generation sequencing (NGS), integration of ai and bioinformatics in diagnostics, government initiatives supporting precision medicine, growing adoption of multi-gene and whole exome panels, increasing demand for personalized cardiovascular care. Major trends in the forecast period include personalized genetic risk profiling, ai-driven diagnostic tools, tele-cardiology and remote monitoring, integration of multi-gene panels, advanced bioinformatics platforms.

The rising prevalence of inherited cardiovascular diseases is expected to drive growth in the cardiogenomics testing panels market. Inherited cardiovascular diseases (ICDs) include heart and blood vessel disorders passed down genetically from parents to offspring. Advances in genetic testing and diagnostics have contributed to an increase in diagnosed cases by enabling more precise detection of previously unidentified conditions. Cardiogenomics testing panels assist in inherited cardiovascular diseases by analyzing genetic mutations responsible for hereditary heart disorders, facilitating early diagnosis, risk evaluation, and personalized treatment plans. For example, in February 2025, the Joint Strategic Needs Assessment, a UK community health center, reported that Blackpool recorded 185 cardiovascular disease deaths in 2023 compared to 178 in 2022. This growing prevalence is fueling expansion in the cardiogenomics testing panels market.

The rising healthcare expenditure is anticipated to drive the expansion of the cardiogenomics testing panels market in the coming years. Healthcare expenditure encompasses the total resources, including funds spent by governments, private entities, and individuals, on providing, maintaining, and enhancing health services and medical care. The increase in healthcare spending is primarily attributed to the growing prevalence of chronic diseases that demand long-term treatment, continuous monitoring, and specialized medical interventions. This expenditure supports cardiogenomics testing panels by financing advanced genetic analyses that allow for the early detection and prevention of inherited cardiovascular diseases, thereby improving patient outcomes and lowering long-term costs. For example, in May 2024, the Office for National Statistics, a UK government department, reported that total healthcare expenditure rose by 5.6% in nominal terms in 2023, marking a 0.9% growth compared to 2022. Consequently, the rising healthcare expenditure fuels the growth of the cardiogenomics testing panels market.

In May 2025, GeneDx Inc., a US-based genetic testing company, completed the acquisition of Fabric Genomics Inc. for an undisclosed sum. Through this acquisition, GeneDx intends to enhance its genomic interpretation capabilities by incorporating Fabric Genomics' AI-powered variant interpretation platform, boosting scalability and diagnostic insights across its testing services. Fabric Genomics, Inc., a US-based genomics and bioinformatics firm, focuses on cardiogenomics testing panels and clinical genetic variant interpretation.

Major companies operating in the cardiogenomics testing panels market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.

North America was the largest region in the cardiogenomics testing panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiogenomics testing panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiogenomics testing panels market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiogenomics testing panels market consists of revenues earned by entities by providing services such as genetic risk assessment, early diagnosis, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiogenomics testing panels market also includes sales of comprehensive cardiomyopathy panels, cardiac arrhythmia panels, and direct-to-consumer genomic profiles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiogenomics Testing Panels Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cardiogenomics testing panels market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiogenomics testing panels ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiogenomics testing panels market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Single-Gene Panels; Multi-Gene Panels; Whole Exome Sequencing Panels
  • 2) By Technology: Next-Generation Sequencing; PCR-Based Testing; Microarray; Other Technologies
  • 3) By Application: Inherited Cardiovascular Diseases; Arrhythmias; Cardiomyopathies; Congenital Heart Diseases; Other Appications
  • 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Single-Gene Panels: Ion Channel Gene Panels; Structural Heart Disease Gene Panels; Arrhythmia Gene Panels
  • 2) By Multi-Gene Panels: Cardiomyopathy Panels; Arrhythmia Panels; Congenital Heart Disease Panels
  • 3) By Whole Exome Sequencing Panels: Targeted Cardiovascular Exome Panels; Comprehensive Exome Panels; Research-Oriented Exome Panels
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; Illumina Inc.; Actia Group; Invitae Corporation; Fulgent Genetics Inc.; GeneDx Inc.; Ambry Genetics Corporation; Helix OpCo Inc.; Centogene Gmbh; Blueprint Genetics Inc.; Strand Life Sciences Pvt. Ltd.; Genes2Me Pvt. Ltd.; BioAro Inc.; GENinCode Plc; Igenomix S.L.; Asper Biotech Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Cardiogenomics Testing Panels Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Cardiogenomics Testing Panels Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Cardiogenomics Testing Panels Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Cardiogenomics Testing Panels Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Personalized Genetic Risk Profiling
    • 4.2.2 Ai-Driven Diagnostic Tools
    • 4.2.3 Tele-Cardiology And Remote Monitoring
    • 4.2.4 Integration Of Multi-Gene Panels
    • 4.2.5 Advanced Bioinformatics Platforms

5. Cardiogenomics Testing Panels Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Academic And Research Institutes
  • 5.4 Cardiology Centers
  • 5.5 Specialized Genetic Testing Centers

6. Cardiogenomics Testing Panels Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiogenomics Testing Panels Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Cardiogenomics Testing Panels PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Cardiogenomics Testing Panels Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Cardiogenomics Testing Panels Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Cardiogenomics Testing Panels Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cardiogenomics Testing Panels Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cardiogenomics Testing Panels Market Segmentation

  • 9.1. Global Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Gene Panels, Multi-Gene Panels, Whole Exome Sequencing Panels
  • 9.2. Global Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Next-Generation Sequencing, PCR-Based Testing, Microarray, Other Technologies
  • 9.3. Global Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Inherited Cardiovascular Diseases, Arrhythmias, Cardiomyopathies, Congenital Heart Diseases, Other Appications
  • 9.4. Global Cardiogenomics Testing Panels Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users
  • 9.5. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Single-Gene Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ion Channel Gene Panels, Structural Heart Disease Gene Panels, Arrhythmia Gene Panels
  • 9.6. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Multi-Gene Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiomyopathy Panels, Arrhythmia Panels, Congenital Heart Disease Panels
  • 9.7. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Whole Exome Sequencing Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Targeted Cardiovascular Exome Panels, Comprehensive Exome Panels, Research-Oriented Exome Panels

10. Cardiogenomics Testing Panels Market Regional And Country Analysis

  • 10.1. Global Cardiogenomics Testing Panels Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Cardiogenomics Testing Panels Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cardiogenomics Testing Panels Market

  • 11.1. Asia-Pacific Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cardiogenomics Testing Panels Market

  • 12.1. China Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cardiogenomics Testing Panels Market

  • 13.1. India Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cardiogenomics Testing Panels Market

  • 14.1. Japan Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cardiogenomics Testing Panels Market

  • 15.1. Australia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cardiogenomics Testing Panels Market

  • 16.1. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cardiogenomics Testing Panels Market

  • 17.1. South Korea Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cardiogenomics Testing Panels Market

  • 18.1. Taiwan Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cardiogenomics Testing Panels Market

  • 19.1. South East Asia Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cardiogenomics Testing Panels Market

  • 20.1. Western Europe Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cardiogenomics Testing Panels Market

  • 21.1. UK Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cardiogenomics Testing Panels Market

  • 22.1. Germany Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cardiogenomics Testing Panels Market

  • 23.1. France Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cardiogenomics Testing Panels Market

  • 24.1. Italy Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cardiogenomics Testing Panels Market

  • 25.1. Spain Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cardiogenomics Testing Panels Market

  • 26.1. Eastern Europe Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cardiogenomics Testing Panels Market

  • 27.1. Russia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cardiogenomics Testing Panels Market

  • 28.1. North America Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cardiogenomics Testing Panels Market

  • 29.1. USA Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cardiogenomics Testing Panels Market

  • 30.1. Canada Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cardiogenomics Testing Panels Market

  • 31.1. South America Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cardiogenomics Testing Panels Market

  • 32.1. Brazil Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cardiogenomics Testing Panels Market

  • 33.1. Middle East Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cardiogenomics Testing Panels Market

  • 34.1. Africa Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cardiogenomics Testing Panels Market Regulatory and Investment Landscape

36. Cardiogenomics Testing Panels Market Competitive Landscape And Company Profiles

  • 36.1. Cardiogenomics Testing Panels Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Cardiogenomics Testing Panels Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Cardiogenomics Testing Panels Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

37. Cardiogenomics Testing Panels Market Other Major And Innovative Companies

  • Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.

38. Global Cardiogenomics Testing Panels Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cardiogenomics Testing Panels Market

40. Cardiogenomics Testing Panels Market High Potential Countries, Segments and Strategies

  • 40.1 Cardiogenomics Testing Panels Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Cardiogenomics Testing Panels Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Cardiogenomics Testing Panels Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer